Loading
companiesCompany
HOVON
aka Haemato Oncology Foundation for Adults in the Netherlands, Stichting Hemato-Oncologie voor Volwassenen Nederland
The Dutch-Belgian adult haematology trials group, one of Europe's largest engines of leukaemia, myeloma and lymphoma phase 3 trials.
Overview
Founded in 1985 and coordinated from Rotterdam, HOVON runs trials across the Netherlands, Belgium and partner countries, often jointly with the Swiss SAKK and the German and Nordic groups. Its AML trials defined intensive induction, consolidation and transplant strategies in adults and the elderly, HOVON-65/GMMG-HD4 established bortezomib in myeloma induction and maintenance, and HOVON lymphoma and CLL studies contribute to European standards. HOVON participates in the European Myeloma Network trials and runs a national data centre and biobank. Most Dutch adults with acute leukaemia are treated within or according to a HOVON protocol.
Headquarters
Rotterdam, NL
Scorecard
All companies#118of 1243 companies, score 46
- approved products +6
- targets +2
- modalities +2
- regions +6
- registry trials +30
1 approved, 0 in phase 3, 0 earlier, 1 targets, 563 registry studies. Formula on the scorecards page.
Website
Founded
1985
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Hovon, including child institutions. 8 works · 207 citations · 63% open access · 25% clinical trials · 0% reviews.
Oncology works per year
32022
22023
22024
12025
02026
Most works
- Martine E.D. Chamuleau4 works
- Marcel Nijland4 works
- Marjolein van der Poel4 works
- Marie José Kersten4 works
- Koen de Heer4 works
- Erik van Werkhoven4 works
- Clara Klerk4 works
- A. Vera de Jonge4 works
- Wassilis S.C. Bruins3 works
- Ram Malladi3 works
Most cited
Marc H.G.P. Raaijmakers
Vice Chair
Myelodysplastic syndromesBone marrow niche biologyHaematology
Erasmus MC haematologist and HOVON Vice Chair known for research on the bone marrow microenvironment in MDS.
Nicolaas P.M. Schaap
Chair
HaematologyStem cell transplantationCellular therapy
Radboudumc haematologist who chairs HOVON, the Dutch-Belgian haemato-oncology cooperative group.
Pieter Sonneveld
Professor of Hematology, Erasmus MC Cancer Institute; Chair, European Myeloma Network
Multiple myelomaTransplant-eligible myelomaDaratumumab quadruplets
Led PERSEUS, which established daratumumab-VRd as the standard for transplant-eligible myeloma.
Notes
top- AML trials (with SAKK)
- Myeloma (HOVON-65/GMMG-HD4, EMN trials)
- Lymphoma and CLL
- National haematology data centre
Similar pages
not linked directly; found by shared links- CompanyLYSA (The Lymphoma Study Association)
Shares German Lymphoma Alliance, International Extranodal Lymphoma Study Group, Hodgkin lymphoma, Diffuse large B-cell lymphoma and the tag cooperative-group.
- CompanyGerman Hodgkin Study Group
Shares German Lymphoma Alliance, Hodgkin lymphoma and the tag cooperative-group.
- CompanyAustralasian Gastro-Intestinal Trials Group
Shares Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing and the tag cooperative-group.
- CompanyChildren's Cancer and Leukaemia Group
Shares MRD / molecular residual disease testing, Acute lymphoblastic leukaemia and the tag cooperative-group.
- CompanyALFA (Acute Leukemia French Association)
Shares Acute myeloid leukaemia and the tag cooperative-group.
- CompanyEuropean Myeloma Network
Shares Multiple myeloma and the tag cooperative-group.
- CompanyFILO (French Innovative Leukemia Organisation)
Shares Acute myeloid leukaemia and the tag cooperative-group.
- CompanyGerman CLL Study Group
Shares Chronic lymphocytic leukaemia and the tag cooperative-group.
cancers
6technologies
1drugs
1ApprovedSmall-molecule BCL-2 inhibitor
Venetoclax · Venclexta